RA-induced differentiation in NB has also been linked to decreased chemosensitivity to antineoplastic agents, such as topotecan, doxorubicin and cisplatin, which is mediated through BCL-2 and BCL-XL upregulation [55]. This evidence concerns the gene BCL2L1 and neuroblastoma.